StockWatch
·
Pharmaceuticals
Corporate Governance20 Jul 2026, 08:10 pm

Bajaj Healthcare: Director Continues Post 75 Years

AI Summary

Bajaj Healthcare Ltd announced the continuation of Mr. Gopalakrishnan Kesavan's directorship as a Non-Executive Independent Director. This decision was approved by the Board of Directors at their meeting held on July 20, 2026, following Mr. Kesavan attaining the age of 75 years. The company confirmed that Mr. Kesavan is not debarred from holding such an office by any regulatory authority. The board meeting also reviewed and approved the un-audited standalone financial results for the quarter ended June 30, 2026, along with the limited review report from statutory auditors Walker Chandiok & Co LLP. The meeting commenced at 5:00 p.m. and concluded at 5:31 p.m.

Key Highlights

  • Director Gopalakrishnan Kesavan's tenure extended post 75 years.
  • Board approved continuation of Non-Executive Independent Director.
  • Unaudited standalone financial results for Q1 FY27 approved.
  • Auditor's limited review report for Q1 FY27 attached.
  • Director confirmed not debarred by any authority.